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Improving Allergy Immunotherapy Adherence
Amy Branham, MSN, FNP-BC
Introduction of the Problem
Allergic rhinoconjunctivitis is a chronic health issue that affects many people. Its
prevalence is increasing worldwide. Consistent with national data regarding allergy
immunotherapy adherence rates, patients at a suburban Midwest teaching clinic often do not
complete their full prescribed course of allergy immunotherapy. This can lead to negative effects
on personal health and overall health system costs. However, there were no plans to improve
adherence to allergy immunotherapy.
Literature Review
Allergic rhinoconjunctivitis (allergic rhinitis) prevalence is increasing worldwide
(Larsen, Broge, & Jacobi, 2016). This has a direct impact on increasing healthcare costs. The
costs related to treating allergic rhinitis increased $5.1 billion from 2000-2005 (Koberlein,
Kothe, Sieber, & Mosges, 2013). Adherence to allergy immunotherapy (AIT) can reduce
healthcare costs (Larsen et al., 2016). AIT is one of the many treatments available for allergic
rhinitis. First line treatment for allergic rhinitis is typically over the counter medications (OTC),
including antihistamines and nasal steroid sprays. AIT is recommended once patients have failed
treatment with OTC medications. AIT is an effective treatment for allergic rhinitis (Demoly,
Passalacqua, Pfaar, Sastre, & Wahn, 2016). AIT is cost effective as it reduces over-the- counter
medication consumption, decreased provider visits, and increased productivity at work and
school (Larsen et al., 2016). AIT has a disease modifying effect which lasts for several years so
this further proves it is cost effective.

There are two methods of AIT, these include subcutaneous immunotherapy (SCIT) or
sublingual immunotherapy (SLIT). SCIT is a subcutaneous injection that is generally given in a
medical office, and it is the predominant method of AIT. SLIT is available in aqueous drops or
tablets and is administered at home. Many clinics offer SCIT. SCIT was found to have a higher
adherence rate (Kiel et al., 2013). However, the adherence rate to the completion of the treatment
course of AIT is suboptimal at 18% (Kiel et al., 2013). Adherence and completion of the AIT
course is key to controlling allergic rhinitis symptoms (Senna, Caminati, & Lockey, 2015).
Adherence to AIT is poor due to the long-term commitment, inconvenient clinic hours,
lack of transportation, costs, adverse reactions, and several other factors (Senna et al., 2015). The
most common reason for non-adherence to AIT was inconvenience, regardless of the type of AIT
(Incorvaia et al., 2008). Four out of ten people were not aware of the long-term commitment
(Senna et al., 2015). Most patients stop treatment in the first month of AIT (Senna et al., 2015).
Forty percent of patients expected an absence of allergies and 20% expected reduced symptoms
days or weeks after starting AIT (Incorvaia et al., 2008).
A patient’s knowledge of AIT and what to expect is the core of increased adherence to
treatment (Incorvaia et al., 2008). The more a patient knows about the treatment and what to
realistically expect can only enhance their adherence to treatment (Demoly et al., 2016).
Education regarding what allergic rhinitis is, definition of respiratory allergy, what allergen
immunotherapy is, and how it works has been found to increase adherence to treatment
(Calderon et al., 2015). A communication template discussing the aforementioned details for
non-adherent patients found 67% would have resumed AIT after viewing the template (Calderon
et al., 2015). Effective communication is the key to successful treatment (Senna et al., 2015).

Patients remember about 60% of what is said to them during their initial visit (Senna et
al., 2015). Redundant education promotes better retention of information and this can increase
adherence (Senna et al., 2015). Calderon et al’s, (2015) template offers key components of AIT
and education that can increase adherence to treatment. The template is conducive to printing in
handouts and other documents that can be revisited by patients. A multi-faceted strategy
including repeated education, regular follow-up visits, and the use of new technology can be
successful to increase adherence to AIT (Senna et al., 2015).
The use of social media and modern technology has the potential to increase adherence to
AIT (Joshi & Dimov, 2014). A 2012 survey of 3,014 of adults living in the United States found
85% own a cell phone (Pew Research Center). Of these cell phone owners, 80% use text
messaging services, and 9% use text messaging regarding health/medical concerns/appointments
(Joshi & Dimov, 2014). Text messaging as a daily/weekly reminder for a patient regarding AIT
can have a positive effect on patient adherence (Joshi & Dimov, 2014). The visual cue acts a
reminder to the patient. Therefore, it is feasible to implement a text message as a reminder to
enhance adherence to AIT.
Project Methods
The goal of this project was to increase subcutaneous immunotherapy adherence rates by
focusing on patient education, text message reminders, and clinic accessibility. Initial
implementation involved working with clinic personnel to develop the content of the reminder
texts and of additional educational materials. The initial project phase began in May 2018 with a
meeting with the allergy program director to develop wording/statement for the text message
reminder and communication/education template, and to discuss the options for increasing the
hours of allergy clinic. A meeting with information technology (IT) in June 2018 was conducted

to discuss ways to have the text message implemented. The text message included the day of the
week and time they are scheduled to come in for their allergy injection. Initially, the text
message was to include the allergy clinic hours, but IT was unable to make this happen due to
software issues not allowing it. The communication/education template included the definition of
respiratory allergy, the symptoms and impact of allergic rhinitis, allergy immunotherapy
benefits, mechanism of action, and anticipated length of treatment. The
communication/education template was printed with the goal of providing it to patients when
they came in for their allergy injections, specifically ones who were non-adherent. At this point
in time, staffing shortages did not allow for increasing the hours of the allergy clinic. However,
clinic accessibility improved when the clinic moved to a free-standing building that housed only
our otolaryngology and allergy clinics. The parking lot is right in front of the building and allows
patients much easier access to the clinic. The planned implementation date for the text message
reminder and teaching materials was June 2018, but this did not occur at that time due to
administrative issues. However, the changes were executed at the beginning of fall. The text
message reminders, which included appointment day and time, were sent to patients who receive
subcutaneous immunotherapy and who had agreed to receive the text. The
communication/education template was given to patients each time they came in for their
injection beginning in September 2018.
To evaluate effectiveness, a convenience sample of individuals receiving subcutaneous
immunotherapy was collected over a 3-month period during the months of September through
December 2018. The adherence rate was measured prior to implementation of the text message
reminder and communication/education template. It was then measured again once the project
was completed. Prior to implementation and collection, an IRB was submitted. The Southern

Illinois University Edwardsville IRB determined that this effort was considered a Quality
Improvement Project (QIP) and did not constitute human subjects research as defined under
45CFR 46.102(l). Therefore, no further action was required prior to starting the implementation.

Evaluation
There were 172 SCIT patients at the clinic. Thirty-nine percent of SCIT patients were
non-adherent to AIT prior to the implementation of this project. Adherence was defined as
patients who routinely come to receive their scheduled injections. Non-adherence was defined as
patients who regularly skip/miss their scheduled injections. During the project, 2 patients moved
out of state, 2 patients had their insurance change and could no longer come to the clinic, and 12
patients dropped out completely. Fourteen of the remaining 51 non-adherent patients became
adherent to AIT as a result of this project. The non-adherence rate went from 39% to 27%.
One week after the project completed a 4-point Likert scale survey was given to patients
to gauge their satisfaction with the text message reminders. Twenty-four surveys were completed
of which 19 indicated they would like the text message reminder to continue. Comments on the
surveys seemed to indicate the texts were helpful in reminding patients to come for their
injections. The text message reminders were being sent 6 days prior to the patient’s scheduled
injection appointment. Of the 19 who wished to continue the text message reminders, they
indicated they would prefer receiving the texts 1-2 days prior to their scheduled injection
appointment. Clinic accessibility was enhanced when the clinic moved locations. However, the
allergy clinic hours remain unchanged due to staffing shortages.

Impact on Practice
Multiple practice improvements were achieved with implementation of this DNP project.
Adherence to AIT improved as a result of the text message reminders and
communication/education template. Patients seemed satisfied with receiving reminders to help
them adhere to their allergy injection regimen. Patients voiced the communication/education
template was helpful and informative.
Future plans include meeting with IT to evaluate the possibility of sending the text
message reminders 1-2 days prior to the scheduled injection appointment. This would be more
helpful and a better reminder for the patients. We anticipate that the long-term impact will
include healthier patients and reduced health care costs. This project can be replicated if the
clinic’s EHR/business software has the capability to send appointment reminders. The
communication/education template can be replicated/reproduced.
Conclusion
Allergic rhinitis is a chronic but treatable health issue. Allergic rhinitis contributes to
increased health care costs and decreased productivity at work and school. AIT is an effective
disease modifying treatment for allergic rhinitis with long-term results. AIT adherence is key in
order to achieve the lasting effects. AIT adherence can be improved with text message reminders
and communication/education templates. Engaging patients with multiple cues can successfully
increase adherence to treatment. Increasing adherence to AIT is worth a shot and will decrease
the ever-growing health care costs.
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